Lithium Carbonate and Oxybutynin Extended-Release Tablets
Determining the interaction of Lithium Carbonate and Oxybutynin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Carbonate-Oxybutynin Gel
- Lithium Carbonate-Oxybutynin Oral Solution
- Lithium Carbonate-Oxybutynin Syrup
- Lithium Carbonate-Oxybutynin Tablets
- Lithium Carbonate-Oxybutynin transdermal
- Lithium Carbonate-Oxybutynin Transdermal System
- Oxybutynin Extended-Release Tablets-Lithium Carbonate ER Tablets
- Oxybutynin Extended-Release Tablets-Lithium Carbonate Tablets
- Oxybutynin Extended-Release Tablets-Lithium Citrate Syrup
- Oxybutynin Extended-Release Tablets-Lithium Controlled-Release and Extended-Release Tablets
- Oxybutynin Extended-Release Tablets-Lithium ER
- Oxybutynin Extended-Release Tablets-Lithium Oral Solution